Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT06422728

The Effectiveness of Transdiagnostic CBT Protocol on Anxiety Disorders

Led by Ibn Haldun University · Updated on 2024-09-19

60

Participants Needed

1

Research Sites

27 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The transdiagnostic approach argues that the common features are needed to be taken into account \[e.g. distress intolerance (DI), intolerance of uncertainty (IU), worry)\] underlying emotional disorders rather than evaluating them separately due to the fact that the dissection of anxiety disorders has increased with each emerging version of the Diagnostic and Statistical Manual of Mental Disorders (DSM), in which the classification of anxiety disorders resulted in an increased number of intervention protocols for each disorder. This also caused an increase of comorbidity among anxiety disorders. Transdiagnostic approach offers a unified protocol (UP) for strengthening the common features, and thereby both preventing the emergence of emotional disorders or intervening the symptom severity of emotional disorders, which can be applied to different types of emotional disorders. The main aim of this study is to develop a UP which is planned to be applied as a group therapy. The UP will include interventions developing the levels of common transdiagnostic features (DI, IU and worry). The study's second aim is to investigate the effect of the developed UP on DI, IU and worry. The third one is to search the effect of the developed UP on symptom severity levels of anxiety disorders. Fourthly, this study will search if the levels of transdiagnostic common features (DI, IU and worry) will predict the levels of symptom severity of anxiety disorders'.

CONDITIONS

Official Title

The Effectiveness of Transdiagnostic CBT Protocol on Anxiety Disorders

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with generalized anxiety disorder, panic disorder, social anxiety disorder, or anxiety disorder not otherwise specified through SCID 5 interview
  • Aged between 18 and 65 years
Not Eligible

You will not qualify if you...

  • Active substance use or psychiatric history related to substance use
  • Co-diagnosis of psychotic disorders or bipolar disorders
  • Currently receiving psychotherapy support
  • Not graduated from primary school

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Iclal AYDIN

Zeyti̇nburnu, Istanbul, Turkey (Türkiye), 34025

Actively Recruiting

Loading map...

Research Team

I

Iclal AYDIN, MA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here